PHS
ANDV

PFM Health Sciences’s Andeavor ANDV Stock Holding History

PFM Health Sciences’s Portfolio ANDV Stock Details ANDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-460,878
Closed -$37.4M – 124
2017
Q1 		$37.4M Buy
+460,878
New +$38.6M 0.94% 45
2014
Q1 		– Sell
-2,005,206
Closed -$117M – 92
2013
Q4 		$117M Buy
+2,005,206
New +$104M 2.36% 16

Other funds holding ANDV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HP
Hound Partners New York $863M AUM 11.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

PFM Health Sciences's ANDV Position: Q2 2017 in Review

PFM Health Sciences sold out of Andeavor (ANDV) in Q2 2017, closing a stake of 460,878 shares — an estimated $37.4M sold.

PFM Health Sciences first reported a position in ANDV in Q4 2013 and held it in 2 quarters. The position peaked at $117M in Q4 2013. 531 funds tracked by Wall St. Rank hold ANDV as of Q2 2017.

  • PFM Health Sciences reported no remaining Andeavor position as of Q2 2017 after selling out during the quarter.
  • PFM Health Sciences sold 460,878 Andeavor shares in Q2 2017, an estimated $37.4M.
  • PFM Health Sciences first reported a position in Andeavor in Q4 2013 and held it in 2 quarters.
  • PFM Health Sciences's Andeavor position peaked at $117M in Q4 2013.
  • 531 funds tracked by Wall St. Rank held Andeavor as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.